Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd

₹ 216 5.00%
21 Feb - close price
About

Incorporated in 1993, Shukra Pharmaceuticals Ltd is engaged in manufacturing and trading of pharmaceuticals products and laboratory testing.

Key Points

Business[1]
The Company is engaged in manufacturing & trading of pharmaceuticals Products and laboratory testing.

  • Market Cap 237 Cr.
  • Current Price 216
  • High / Low 216 / 41.8
  • Stock P/E 12.8
  • Book Value 40.8
  • Dividend Yield 0.23 %
  • ROCE 18.8 %
  • ROE 21.2 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 52.8% CAGR over last 5 years
  • Company's working capital requirements have reduced from 130 days to 49.0 days

Cons

  • Stock is trading at 5.30 times its book value
  • Company has a low return on equity of 10.1% over last 3 years.
  • Company has high debtors of 187 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
4.15 4.26 2.96 2.98 2.89 8.94 6.57 3.72 2.30 46.25 20.16 24.64 18.89
3.76 3.80 2.75 4.92 2.52 7.36 5.61 3.25 2.02 42.60 19.82 19.55 9.34
Operating Profit 0.39 0.46 0.21 -1.94 0.37 1.58 0.96 0.47 0.28 3.65 0.34 5.09 9.55
OPM % 9.40% 10.80% 7.09% -65.10% 12.80% 17.67% 14.61% 12.63% 12.17% 7.89% 1.69% 20.66% 50.56%
0.27 -0.35 0.23 2.40 0.13 0.04 0.01 0.03 0.27 0.89 0.63 0.24 0.56
Interest 0.00 0.03 0.02 0.02 0.04 0.21 0.12 0.04 0.05 0.07 0.08 0.06 0.07
Depreciation 0.36 0.39 0.37 0.37 0.37 0.56 0.42 0.45 0.46 0.51 0.46 0.56 0.51
Profit before tax 0.30 -0.31 0.05 0.07 0.09 0.85 0.43 0.01 0.04 3.96 0.43 4.71 9.53
Tax % 30.00% 25.81% 20.00% 85.71% 44.44% 23.53% 23.26% -700.00% 50.00% -0.25% 2.33% -0.21% 1.05%
0.21 -0.23 0.04 0.02 0.05 0.65 0.33 0.08 0.03 3.98 0.42 4.71 9.42
EPS in Rs 0.19 -0.21 0.04 0.02 0.05 0.59 0.30 0.07 0.03 3.62 0.38 4.35 8.71
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
7 5 4 3 5 5 5 6 12 11 20 59 110
6 5 5 3 4 4 4 4 10 10 18 53 91
Operating Profit 0 0 -0 -0 1 1 2 2 2 1 3 5 19
OPM % 4% 9% -2% -10% 24% 28% 30% 29% 13% 13% 14% 9% 17%
2 -3 0 1 -0 0 0 0 0 0 0 1 2
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 1 1 1 0 0 1 1 1 1 2 2 2
Profit before tax 2 -3 -1 0 0 1 1 1 0 0 1 4 19
Tax % 54% 0% -9% 52% 66% 52% 45% 37% 82% -90% 26% 1%
1 -3 -1 0 0 0 1 0 0 0 1 4 19
EPS in Rs 0.11 -0.35 -0.69 0.12 0.11 0.45 0.48 0.42 0.04 0.17 0.68 4.01 17.06
Dividend Payout % 0% 0% 0% 0% 0% 16% 15% 17% 0% 0% 10% 4%
Compounded Sales Growth
10 Years: 28%
5 Years: 62%
3 Years: 71%
TTM: 411%
Compounded Profit Growth
10 Years: 36%
5 Years: 53%
3 Years: 504%
TTM: 1600%
Stock Price CAGR
10 Years: 91%
5 Years: 108%
3 Years: 185%
1 Year: 230%
Return on Equity
10 Years: 4%
5 Years: 7%
3 Years: 10%
Last Year: 21%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 9 10 2 2 2 2 2 2 2 2 2 4 11
Reserves -8 -11 12 12 13 13 13 14 14 14 15 21 33
10 10 0 1 0 0 4 6 8 10 3 5 2
4 4 4 3 3 4 6 7 10 10 15 45 28
Total Liabilities 16 14 18 18 17 19 24 28 34 36 35 75 74
2 10 10 10 10 10 14 16 17 18 18 20 20
CWIP 0 0 2 2 2 2 2 2 2 2 2 2 2
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
14 3 7 7 6 7 8 11 14 16 16 53 52
Total Assets 16 14 18 18 17 19 24 28 34 36 35 75 74

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-7 -12 -3 -2 3 -0 1 0 1 1 8 3
2 2 -10 1 -0 -1 -5 -2 -3 -2 -2 -4
5 5 -18 1 -1 0 3 2 2 2 -7 5
Net Cash Flow -0 -5 -31 0 1 -1 -0 0 -0 0 -0 4

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 231 92 45 73 71 175 200 345 245 318 132 187
Inventory Days 72 145 134 554 92 112 53 100 169 221 139 25
Days Payable 94 173 209 291 108 400 734 1,161 786 702 303 276
Cash Conversion Cycle 209 64 -30 335 54 -112 -480 -717 -372 -163 -32 -63
Working Capital Days 640 111 368 758 258 344 379 440 226 278 61 49
ROCE % -2% -2% -6% -1% 6% 7% 6% 4% 0% 1% 6% 19%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
49.17% 49.17% 49.17% 49.17% 49.17% 49.17% 49.16% 49.16% 50.90% 50.90% 50.90% 50.95%
0.80% 0.80% 0.80% 0.80% 0.80% 0.80% 0.80% 0.80% 0.11% 0.11% 0.11% 0.11%
50.04% 50.04% 50.04% 50.04% 50.04% 50.04% 50.04% 50.04% 48.99% 48.99% 48.99% 48.93%
No. of Shareholders 9,3459,3459,3059,2689,2399,1939,2379,2349,5319,5829,74710,963

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents